Media Room - News Release

THE SOLAE COMPANY FILES PATENT INFRINGEMENT SUIT AGAINST ADM, AMERIFIT
Suit Comes as The Solae Company Introduces New Offering of Soy Isoflavone Concentrates for Developers of Dietary Supplements

ST. LOUIS, June 4, 2003 –The Solae Company today announced that it has filed a complaint in the District Court of Eastern Missouri against Archer Daniels Midland Company (NYSE: ADM) and Amerifit Nutrition, Inc., asserting that ADM’s Novasoy® isoflavone products and the Estroven® health supplement products marketed by Amerifit infringe certain patent rights of The Solae Company.

“The Solae Company has spent many years investing in soy isoflavone concentrates and will aggressively defend its associated intellectual property portfolio when it is threatened,” said Tony Arnold, CEO of The Solae Company. “Our soy isoflavone patents are an extremely valuable corporate asset, and this suit reflects our determination to protect that value.”

“The Solae Company has recently introduced a broad offering of soy isoflavone concentrates, reflecting more than a decade of substantial scientific research. In offering these concentrates to the industry, we look forward to working more closely with major developers of dietary supplements to share the health benefits of soy with consumers worldwide,” said Arnold.

The Solae Company, based in St. Louis, Missouri, serves food and beverage manufacturers, dietary supplement developers, retailers and consumers in 100 countries worldwide including the United States and Canada, Europe and Middle East, Latin America and the Asia/Pacific region. The company is part of an alliance between Bunge Limited (NYSE: BG) and DuPont (NYSE: DD). The company’s business is focused on significantly growing the global business in plant-based, specialty food ingredients, initially addressing soy protein and lecithin, soy isoflavones, and expanded offerings of products and services that help customers compete and prosper.

# # #